Endothelial cells are main producers of interleukin 8 through toll-like receptor 2 and 4 signaling during bacterial infection in leukopenic cancer patients

Clinical and Diagnostic Laboratory Immunology

Volumn 10, Issue 4, 2003, Pages 558-563

  Nijhuis, C S M Oude ^a   Vellenga, E ^b   Daenen, S M G J ^b   Kamps, W A ^a   De Bont, E S J M ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; NEUTRALIZING ANTIBODY; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERIAL INFECTION; CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CELL COUNT; CIRCULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENDOTHELIUM CELL; FEMALE; GRAM NEGATIVE BACTERIUM; HUMAN; HUMAN CELL; INFECTION RISK; INFLAMMATION; LEUKOCYTE; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SUPERNATANT;

ADULT; ANTINEOPLASTIC AGENTS; BACTERIAL INFECTIONS; BLOOD PHYSIOLOGY; CELLS, CULTURED; CHILD; CULTURE MEDIA; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION, NEOPLASTIC; HEMATOLOGIC NEOPLASMS; HUMANS; INTERLEUKIN-8; LEUKOPENIA; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; NEOPLASMS; PROSPECTIVE STUDIES; RECEPTORS, CELL SURFACE; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0038783229     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.10.4.558-563.2003     Document Type: Article

References (33)

1. American College of Chest Physicians/Society of Critical Care Medicine. 1992. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med. 20:864-874.
2. Arbour, N. C., E. Lorenz, B. C. Schutte, J. Zabner, J. N. Kline, M. Jones, K. Frees, J. L. Watt, and D. A. Schwartz. 2000. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 25:187-191.
3. Bodey, G. P., M. Buckley, Y. S. Sathe, and E. J. Freireich. 1966. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann. Intern. Med. 64:328-340.
4. Brown, A. E. 1984. Neutropenia, fever, and infection. Am. J. Med. 76:421-428.
5. Bruserud, O., P. E. Akselen, J. Bergheim, and I. Nesthus. 1995. Serum concentrations of E-selectin, P-selectin, ICAM-1 and interleukin 6 in acute leukaemia patients with chemotherapy-induced leucopenia and bacterial infections. Br. J. Haematol. 91:394-402.
6. Bruserud, O., J. Bergheim, F. V. Shammas, and I. Nesthus. 1994. Serum concentrations of tumour necrosis factor-alpha during chemotherapy-induced leukopenia in patients with acute leukaemia and bacterial infections. Leuk. Res. 18:415-421.
7. Cannon, J. G., R. G. Tompkins, J. A. Gelfand, H. R. Michie, G. G. Stanford, J. W. van der Meer, S. Endres, G. Lonnemann, J. Corsetti, and B. Chernow. 1990. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J. Infect. Dis. 161:79-84.
8. de Bont, E. S., J. L. Kimpen, R. Y. Tamminga, A. E. Niemarkt, L. H. de Leij, and W. A. Kamps. 2000. Intrinsic capacity of monocytes to produce cytokines ex vivo in patients with acute lymphoblastic leukaemia. Cytokine 12:1723-1726.
9. de Bont, E. S., E. Vellenga, J. C. Swaanenburg, V. Fidler, P. J. Visser-van Brummen, and W. A. Kamps. 1999. Plasma IL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia. Br. J. Haematol. 107:375-380.
10. Denecker, N. E., B. J. Kullberg, J. P. Drenth, J. M. Raemaekers, and J. W. Van der Meer. 1997. Regulation of the production of pro-inflammatory cytokines and antagonists during chemotherapy-induced neutropenia in patients with haematological malignancies. Cytokine 9:702-710.
11. Denizot, Y., P. Fixe, E. Liozon, and V. Praloran. 1996. Serum interleukin-8 (IL-8) and IL-6 concentrations in patients with hematologic malignancies. Blood 87:4016-4017.
12. Engel, A., E. Mack, P. Kern, and W. V. Kern. 1998. An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients. Infection 26:213-221.
13. Faure, E., O. Equils, P. A. Sieling, L. Thomas, F. X. Zhang, C. J. Kirschning, N. Polentarutti, M. Muzio, and M. Arditi. 2000. Bacterial lipopolysaccharide activates NF-kappaB through Toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. J. Biol. Chem. 275:11058-11063.
14. Greendyke, R. M., K. Sharma, and F. R. Gifford. 1994. Serum cytokine levels in patients with neutropenia. Arch. Pathol. Lab. Med. 118:1193-1195.
15. Heney, D., I. J. Lewis, S. W. Evans, R. Banks, C. C. Bailey, and J. T. Whicher. 1992. Interleukin-6 and its relationship to C-reactive protein and fever in children with febrile neutropenia. J. Infect. Dis. 165:886-890.
16. Herrmann, J. L., H. Blanchard, P. Brunengo, and P. H. Lagrange. 1994. TNF alpha, IL-1 beta and IL-6 plasma levels in neutropenic patients after onset of fever and correlation with the C-reactive protein (CRP) kinetic values. Infection 22:309-315.
17. Hippenstiel, S., S. Soeth, B. Kellas, O. Fuhrmann, J. Seybold, M. Krull, C. Eichel-Streiber, M. Goebeler, S. Ludwig, and N. Suttorp. 2000. Rho proteins and the p38-MAPK pathway are important mediators for LPS-induced interleukin-8 expression in human endothelial cells. Blood 95:3044-3051.
18. Jack, R. S., X. Fan, M. Bernheiden, G. Rune, M. Ehlers, A. Weber, G. Kirsch, R. Mentel, B. Furll, M. Freudenberg, G. Schmitz, F. Stelter, and C. Schutt. 1997. Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infection. Nature 389:742-745.
19. Kaisho, T., and S. Akira. 2000. Critical roles of Toll-like receptors in host defense. Crit. Rev. Immunol. 20:393-405.
20. Kern, W. V., M. Heiss, and G. Steinbach. 2001. Prediction of gram-negative bacteremia in patients with cancer and febrile neutropenia by means of interleukin-8 levels in serum: targeting empirical monotherapy versus combination therapy. Clin. Infect. Dis. 32:832-835.
21. Kopp, E. B., and R. Medzhitov. 1999. The Toll-receptor family and control of innate immunity. Curr. Opin. Immunol. 11:13-18.
22. Lehrnbecher, T., D. Venzon, M. de Haas, S. J. Chanock, and J. Kuhl. 1999. Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia. Clin. Infect. Dis. 29:414-419.
23. Ostermann, H., M. Rothenburger, R. M. Mesters, J. van de Loo, and J. Kienast. 1994. Cytokine response to infection in patients with acute myelogenous leukaemia following intensive chemotherapy. Br. J. Haematol. 88:332-337.
24. Poltorak, A., X. He, I. Smirnova, M. Y. Liu, C. V. Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, M. Freudenberg, P. Ricciardi-Castagnoli, B. Layton, and B. Beutler. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085-2088.
25. Qureshi, S. T., L. Lariviere, G. Leveque, S. Clermont, K. J. Moore, P. Gros, and D. Malo. 1999. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J. Exp. Med. 189:615-625.
26. Schwandner, R., R. Dziarski, H. Wesche, M. Rothe, and C. J. Kirschning. 1999. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2. J. Biol. Chem. 274:17406-17409.
27. Shimazu, R., S. Akashi, H. Ogata, Y. Nagai, K. Fukudome, K. Miyake, and M. Kimoto. 1999. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189:1777-1782.
28. Takamatsu, Y., K. Akashi, M. Harada, T. Teshima, S. Inaba, K. Shimoda, T. Eto, T. Shibuya, S. Okamura, and Y. Niho. 1993. Cytokine production by peripheral blood monocytes and T cells during haemopoietic recovery after intensive chemotherapy. Br. J. Haematol. 83:21-27.
29. Tracey, K. J., B. Beutler, S. F. Lowry, J. Merryweather, S. Wolpe, I. W. Milsark, R. J. Hariri, T. J. Fahey III, A. Zentella, and J. D. Albert. 1986. Shock and tissue injury induced by recombinant human cachectin. Science 234:470-474.
30. Waage, A., D. Remick, S. Steinshamn, L. Deforge, and J. Lamvik. 1994. Interleukin 8 in serum in granulocytopenic patients with infections. Br. J. Haematol. 86:36-40.
31. Wang, Q., R. Dziarski, C. J. Kirschning, M. Muzio, and D. Gupta. 2001. Micrococci and peptidoglycan activate TLR2→MyD88→IRAK→TRAF→ NIK→IKK→NF-κB signal transduction pathway that induces transcription of interleukin-8. Infect. Immun. 69:2270-2276.
32. Yang, R. B., M. R. Mark, A. Gray, A. Huang, M. H. Xie, M. Zhang, A. Goddard, W. I. Wood, A. L. Gurney, and P. J. Godowski. 1998. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 395:284-288.
33. Yang, R. B., M. R. Mark, A. L. Gurney, and P. J. Godowski. 1999. Signaling events induced by lipopolysaccharide-activated Toll-like receptor 2. J. Immunol. 163:639-643.